COVID-19: India approves Gilead’s remdesivir to treat severe COVID-19 cases

BENGALURU, June 3 (Reuters) - India's government has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use for five doses in treating COVID-19 patients....

read more...

Published By: dailymaverick - Wednesday, 3 June